Deep learning-based intraoperative differentiation of primary CNS lymphoma and glioma: a discovery, multicenter validation, and proof-of concept study

Author:

Zhang Xinke1,Zhao Zihan1,Wang Ruixuan2,Chen Haohua1,Zheng Xueyi1,Liu Lili1,Lan Lilong1,Li Peng1,Wu Shuyang1,Cao Qinghua3,Luo Rongzhen1,Ye Yaping4,Wang Yu5,Xie Dan6ORCID,Cai Mu-Yan7ORCID

Affiliation:

1. Sun Yat-sen University Cancer Center

2. School of Information Science and Technology, Sun Yat-sen University, Guangzhou, Guangdong, China

3. The First Affiliated Hospital, Sun Yat-sen University

4. Department of Pathology, Nanfang Hospital, Soutern Medical University

5. Department of Pathology, Zhujiang Hospital, Soutern Medical University

6. State key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Sun Yat-Sen University

7. Department of Pathology, Sun Yat-Sen University Cancer Center

Abstract

Abstract Intraoperative differentiation of primary central nervous system lymphoma (PCNSL) and glioma is of great importance to decision-making for neurosurgeons. However, distinguishing these two diseases based on frozen sections presents a challenge for pathologists. Here, we aim to develop and validate a deep learning model (LGNet) that could accurately differentiate PCNSL from glioma on haematoxylin and eosin (H&E)-stained frozen whole-slide images. In this study, the LGNet was developed and validated to distinguish PCNSL from glioma on independent cohorts, and its performance was compared to that of three pathologists with varying levels of expertise. Additionally, a human-machine fusion approach was designed to consider the diagnostic results from both pathologist and LGNet, to improve the integrative diagnostic performance. A proof of concept study was further evaluated with an online pathological decision support platform. The LGNet achieved high area under the receiver operating characteristic curves (AUROCs) of 0·965 and 0·972 for discriminating PCNSL and glioma on the two external validation cohorts. Moreover, the LGNet outperformed the three pathologists, and assisted them in making the distinction. The diagnostic performance human-machine fusion was further improved using the human-machine fusion. Notably, the performance of LGNet was verified with the proof of concept cohort, and it was shown that the time-consumption of LGNet was significantly less than that of pathologists (P < 0·001) in practical scenario. Also, the study demonstrated the association between histopathological characteristics and the LGNet’s prediction as derived from the logistic regression model. These findings suggest that the LGNet accurately and timely differentiates PCNSL from glioma based on frozen sections, and adds to the enhancement of pathologists’ diagnostic performance. Thus, our deep learning model LGNet has the application potential during intraoperative diagnosis.

Publisher

Research Square Platform LLC

Reference42 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009;Dolecek TA;Neuro Oncol,2012

2. A.J.M. How we treat primary central nervous system lymphoma;Calimeri T;ESMO Open,2021

3. Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?;Tom MC;Am Soc Clin Oncol Educ Book,2019

4. Intraoperative diagnosis of nervous system lesions;Stefano D;Acta Cytol,1998

5. Intraoperative consultation for nervous system lesions;Yachnis AT;Semin Diagn Pathol,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3